Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Pharmacol Ther. 2018 Nov 9;195:172–185. doi: 10.1016/j.pharmthera.2018.11.001

Table 3.

The effect of age on methylation of specific CpG sites in the genome.

Age Sex Tissue/cell type Method CpG sites
References
Total Sites Studied Total changed Hyper-methylated Hypo-methylated
Humansa
19–101 M & F Blood Array 485,577 70,387 (14.5%) _ Hannum et al., 2013
34–61 M PBMC Array 463,228 10,625 (2.3%) 7081 3544 Steegenga et al., 2014
28–64 M & F Liver Array 455,526 20,396 (4.4%) 19,548 848 Bysani et al., 2017
Miceb
4 & 24 M (C57Bl/6) HSC WGBS ~20 million 448,166 (2.2%) 275,622 172,543 Sun et al., 2014
3 & 24 M (C57Bl/6) Hippocampus BOCS ~3 million 36,170 (1.2%) 21,295 14,294 Masser et al., 2017
3 & 24 F (C57Bl/6) Hippocampus BOCS ~ 3 million 48,410 (1.6%) 27,987 19,842 Masser et al., 2017
5 & 27 F (C3B6F1) Liver BS-Seq ~29 million 79,400 (0.3%) 48,625 30,775 Hahn et al., 2017
2 & 22 M (UM-Het3) Liver WGBS ~ 21 million 49,899 * 14,365* 35,534* Cole et al., 2017
3 & 24 M (C57Bl/6) Hippocampus BOCS ~2 million 41,585 (2.0%) 26,180 15,425 Hadad et al., 2018

M&F–samplesfrom malesand femalescombined fordata generation

a

humanageinyears

b

mouseage inmonths;WGBS- WholeGenomeBisulfiteSequencing;BOCS-BisulfiteoligonucleotideCapture Sequencing; BS-Seq-Bisulfite Sequencing; Array-Illumi na BeadChip

*

- numbers represent differential methylated regionsand not CpG sites.